Skip to main content
Erschienen in: High Blood Pressure & Cardiovascular Prevention 5/2022

01.09.2022 | Original article

High-Sensitivity Cardiac Troponin I Levels Below 99th Percentile Upper Reference Limit in Patients Presenting with Suspicion of Acute Coronary Syndrome (ACS) in Emergency Department at a Tertiary Care Hospital in Karachi, Pakistan

verfasst von: Fatima Kanani, Adnan M. Zubairi, Maliha Zubairy, Sidra Maqsood

Erschienen in: High Blood Pressure & Cardiovascular Prevention | Ausgabe 5/2022

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Troponin I levels are biomarkers of choice for diagnosis of acute myocardial infarction (AMI). However, prognostic significance of values below the 99th percentile upper reference limit (URL) in patients presenting with symptoms suggestive of Acute coronary syndrome (ACS) need further evaluation.

Aim

The objectives of the study were to find the association of High sensitivity (hs)-Troponin I values below 99th percentile URL with age and the Emergency Department (ED) outcome, to determine single cut-off for safe discharge of these patients from the ED and to determine the 30-day outcome of the patients admitted under cardiac speciality.

Methods

This is a retrospective study of patients presenting with suspicion of ACS in the ED between January 2019 till April 2021 and hs-Troponin I values below 99th percentile URL.

Results

Among 15,441 patients, 8034 (52%) were males and 7407 (48%) were females. 9677 (63%) of the patients had hs-Troponin I values < 5 ng/L while 5764 (37%) had values between 5 ng/L and 99th percentile URL. Higher hs-Troponin I values were associated with a worse ED outcome. Serial troponin I levels were performed in only 2.4% of the cohort. Receiver operating characteristics for ACS demonstrated an AUC of 0.84 at a cut off value of 12.75 ng/L, with sensitivity (76.9%) and specificity was 75.1%. The 30-day outcome of the patients admitted under cardiac speciality revealed no mortality in either group.

Conclusion

An overall single cut-off value of 12.75 ng/L can be used in our population for ruling our ACS provided it is unaccompanied by other supportive clinical and ECG findings.
Literatur
1.
Zurück zum Zitat Apple FS, Collinson PO, Biomarkers ITFoCAoC. Analytical characteristics of high-sensitivity cardiac troponin assays. Clin Chem 2012; 58:54-61. Apple FS, Collinson PO, Biomarkers ITFoCAoC. Analytical characteristics of high-sensitivity cardiac troponin assays. Clin Chem 2012; 58:54-61.
2.
Zurück zum Zitat Thygesen K. “Ten commandments” for the fourth universal definition of myocardial infarction 2018. Eur Heart J. 2019;40:226.CrossRef Thygesen K. “Ten commandments” for the fourth universal definition of myocardial infarction 2018. Eur Heart J. 2019;40:226.CrossRef
3.
Zurück zum Zitat Tada M, Azuma H, Yamada N, Kano KI, Nagai H, Maeda S, et al. A comprehensive validation of very early rule-out strategies for non-ST-segment elevation myocardial infarction in emergency departments: protocol for a multicentre prospective cohort study. BMJ Open. 2019;9: e026985.CrossRef Tada M, Azuma H, Yamada N, Kano KI, Nagai H, Maeda S, et al. A comprehensive validation of very early rule-out strategies for non-ST-segment elevation myocardial infarction in emergency departments: protocol for a multicentre prospective cohort study. BMJ Open. 2019;9: e026985.CrossRef
4.
Zurück zum Zitat Body R, Morris N, Collinson P. Single test rule-out of acute myocardial infarction using the limit of detection of a new high-sensitivity troponin I assay. Clin Biochem. 2020;78:4–9.CrossRef Body R, Morris N, Collinson P. Single test rule-out of acute myocardial infarction using the limit of detection of a new high-sensitivity troponin I assay. Clin Biochem. 2020;78:4–9.CrossRef
5.
Zurück zum Zitat Goorden SM, van Engelen RA, Wong LS, van der Ploeg T, Verdel GJ, Buijs MM. A novel troponin I rule-out value below the upper reference limit for acute myocardial infarction. Heart. 2016;102:1721–7.CrossRef Goorden SM, van Engelen RA, Wong LS, van der Ploeg T, Verdel GJ, Buijs MM. A novel troponin I rule-out value below the upper reference limit for acute myocardial infarction. Heart. 2016;102:1721–7.CrossRef
6.
Zurück zum Zitat Chapman AR, Anand A, Boeddinghaus J, Ferry AV, Sandeman D, Adamson PD, et al. Comparison of the efficacy and safety of early rule-out pathways for acute myocardial infarction. Circulation. 2017;135:1586–96.CrossRef Chapman AR, Anand A, Boeddinghaus J, Ferry AV, Sandeman D, Adamson PD, et al. Comparison of the efficacy and safety of early rule-out pathways for acute myocardial infarction. Circulation. 2017;135:1586–96.CrossRef
7.
Zurück zum Zitat Sharrod-Cole H, Ford C. Multicenter evaluation of a high-sensitivity Troponin I assay and verification of an early rule-out algorithm. J Appl Lab Med. 2019;4:95–100.CrossRef Sharrod-Cole H, Ford C. Multicenter evaluation of a high-sensitivity Troponin I assay and verification of an early rule-out algorithm. J Appl Lab Med. 2019;4:95–100.CrossRef
8.
Zurück zum Zitat Liu JY, Jia QW, Zang XL, Wang RH, Li CJ, Wang LS, et al. Age-sex distribution of patients with high-sensitivity troponin T levels below the 99th percentile. Oncotarget. 2017;8:75638–45.CrossRef Liu JY, Jia QW, Zang XL, Wang RH, Li CJ, Wang LS, et al. Age-sex distribution of patients with high-sensitivity troponin T levels below the 99th percentile. Oncotarget. 2017;8:75638–45.CrossRef
9.
Zurück zum Zitat Martin AK, Malhotra AK, Sullivan BL, Ramakrishna H. Troponin elevations in patients with chronic cardiovascular disease: an analysis of current evidence and significance. Ann Card Anaesth. 2016;19:321–7.CrossRef Martin AK, Malhotra AK, Sullivan BL, Ramakrishna H. Troponin elevations in patients with chronic cardiovascular disease: an analysis of current evidence and significance. Ann Card Anaesth. 2016;19:321–7.CrossRef
10.
Zurück zum Zitat Lan NSR, Bell DA. Revisiting the biological variability of cardiac troponin: implications for clinical practice. Clin Biochem Rev. 2019;40:201–16.CrossRef Lan NSR, Bell DA. Revisiting the biological variability of cardiac troponin: implications for clinical practice. Clin Biochem Rev. 2019;40:201–16.CrossRef
11.
Zurück zum Zitat Herman DS, Kavsak PA, Greene DN. Variability and error in cardiac troponin TestingAn ACLPS critical review. Am J Clin Pathol. 2017;148:281–95.CrossRef Herman DS, Kavsak PA, Greene DN. Variability and error in cardiac troponin TestingAn ACLPS critical review. Am J Clin Pathol. 2017;148:281–95.CrossRef
12.
Zurück zum Zitat Tanindi A, Cemri M. Troponin elevation in conditions other than acute coronary syndromes. Vasc Health Risk Manag. 2011;7:597–603.CrossRef Tanindi A, Cemri M. Troponin elevation in conditions other than acute coronary syndromes. Vasc Health Risk Manag. 2011;7:597–603.CrossRef
13.
Zurück zum Zitat Kanani FZ, Kazmi AH. False-positive high sensitivity troponin I on Alinity I. Eur J Med Case Rep. 2020;4:301–4.CrossRef Kanani FZ, Kazmi AH. False-positive high sensitivity troponin I on Alinity I. Eur J Med Case Rep. 2020;4:301–4.CrossRef
14.
Zurück zum Zitat Gore MO, de Lemos JA. Clinical relevance of the 99th percentile upper reference limit for high-sensitivity cardiac troponin assays. Clin Chem. 2020;66:403–5.CrossRef Gore MO, de Lemos JA. Clinical relevance of the 99th percentile upper reference limit for high-sensitivity cardiac troponin assays. Clin Chem. 2020;66:403–5.CrossRef
15.
Zurück zum Zitat Collinson PO, Heung YM, Gaze D, Boa F, Senior R, Christenson R, et al. Influence of population selection on the 99th percentile reference value for cardiac troponin assays. Clin Chem. 2012;58:219–25.CrossRef Collinson PO, Heung YM, Gaze D, Boa F, Senior R, Christenson R, et al. Influence of population selection on the 99th percentile reference value for cardiac troponin assays. Clin Chem. 2012;58:219–25.CrossRef
16.
Zurück zum Zitat Kalaria TR, Harris N, Sensi H, Valentine R, Asif U, Sharrod-Cole H, et al. High-sensitivity cardiac troponin I: is ethnicity relevant? J Clin Pathol. 2021;74:709–11.CrossRef Kalaria TR, Harris N, Sensi H, Valentine R, Asif U, Sharrod-Cole H, et al. High-sensitivity cardiac troponin I: is ethnicity relevant? J Clin Pathol. 2021;74:709–11.CrossRef
17.
Zurück zum Zitat Bahadur K, Ijaz A, Salahuddin M, Alam A. Determination of high sensitive cardiac troponin I 99th percentile upper reference limits in a healthy Pakistani population. Pak J Med Sci. 2020;36:1303–7.CrossRef Bahadur K, Ijaz A, Salahuddin M, Alam A. Determination of high sensitive cardiac troponin I 99th percentile upper reference limits in a healthy Pakistani population. Pak J Med Sci. 2020;36:1303–7.CrossRef
18.
Zurück zum Zitat Bardaji A, Bonet G, Carrasquer A, Gonzalez-Del Hoyo M, Dominguez F, Sanchez R, et al. Prognostic implications of detectable cardiac troponin I below the 99th percentile in patients admitted to an emergency department without acute coronary syndrome. Clin Chem Lab Med. 2018;56:1954–61.CrossRef Bardaji A, Bonet G, Carrasquer A, Gonzalez-Del Hoyo M, Dominguez F, Sanchez R, et al. Prognostic implications of detectable cardiac troponin I below the 99th percentile in patients admitted to an emergency department without acute coronary syndrome. Clin Chem Lab Med. 2018;56:1954–61.CrossRef
19.
Zurück zum Zitat Kavsak PA, Wang X, Ko DT, MacRae AR, Jaffe AS. Short- and long-term risk stratification using a next-generation, high-sensitivity research cardiac troponin I (hs-cTnI) assay in an emergency department chest pain population. Clin Chem. 2009;55:1809–15.CrossRef Kavsak PA, Wang X, Ko DT, MacRae AR, Jaffe AS. Short- and long-term risk stratification using a next-generation, high-sensitivity research cardiac troponin I (hs-cTnI) assay in an emergency department chest pain population. Clin Chem. 2009;55:1809–15.CrossRef
20.
Zurück zum Zitat Kelly AM, Klim S. Does undetectable troponin I at presentation using a contemporary sensitive assay rule out myocardial infarction? A cohort study. Emerg Med J. 2015;32:760–3.CrossRef Kelly AM, Klim S. Does undetectable troponin I at presentation using a contemporary sensitive assay rule out myocardial infarction? A cohort study. Emerg Med J. 2015;32:760–3.CrossRef
21.
Zurück zum Zitat Neumann JT, Sorensen NA, Ojeda F, Renne T, Schnabel RB, Zeller T, et al. Early diagnosis of acute myocardial infarction using high-sensitivity troponin I. PLoS One. 2017;12: e0174288.CrossRef Neumann JT, Sorensen NA, Ojeda F, Renne T, Schnabel RB, Zeller T, et al. Early diagnosis of acute myocardial infarction using high-sensitivity troponin I. PLoS One. 2017;12: e0174288.CrossRef
22.
Zurück zum Zitat Julicher P, Greenslade JH, Parsonage WA, Cullen L. The organisational value of diagnostic strategies using high-sensitivity troponin for patients with possible acute coronary syndromes: a trial-based cost-effectiveness analysis. BMJ Open. 2017;7: e013653.CrossRef Julicher P, Greenslade JH, Parsonage WA, Cullen L. The organisational value of diagnostic strategies using high-sensitivity troponin for patients with possible acute coronary syndromes: a trial-based cost-effectiveness analysis. BMJ Open. 2017;7: e013653.CrossRef
Metadaten
Titel
High-Sensitivity Cardiac Troponin I Levels Below 99th Percentile Upper Reference Limit in Patients Presenting with Suspicion of Acute Coronary Syndrome (ACS) in Emergency Department at a Tertiary Care Hospital in Karachi, Pakistan
verfasst von
Fatima Kanani
Adnan M. Zubairi
Maliha Zubairy
Sidra Maqsood
Publikationsdatum
01.09.2022
Verlag
Springer International Publishing
Erschienen in
High Blood Pressure & Cardiovascular Prevention / Ausgabe 5/2022
Print ISSN: 1120-9879
Elektronische ISSN: 1179-1985
DOI
https://doi.org/10.1007/s40292-022-00532-7

Weitere Artikel der Ausgabe 5/2022

High Blood Pressure & Cardiovascular Prevention 5/2022 Zur Ausgabe

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.